Almost two in five physicians suffered moral distress in the two weeks leading up to their being asked about it by researchers. That was a markedly larger slice than the team observed in the general U.S. working population.
New findings suggest that the procedure offers effective local control and a favorable safety profile for patients with medically inoperable stage 1A non-small cell lung cancer.
Gadolinium-153, or Gd-153, is routinely used to calibrate nuclear imaging equipment. It has been in short supply since 2023 when global distribution of the radioisotope came to a halt.
A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.
The high-risk patients who require urgent or emergent TAVR are often excluded from major clinical trials. To learn more about this population, researchers explored data from nearly 600 patients treated at high-volume facilities.
Regulators recently scolded the France-based pharmaceutical firm for safety issues that occurred at its plant in Raleigh, North Carolina, which produces imaging contrast agents.
The U.S. Department of Justice is appealing a lower court’s ruling that would see 16,000 federal employees return to work, including many from Veterans Affairs.
The subcutaneous drug, sold under the brand name Amvuttra, joins an ATTR-CM market that already includes Pfizer’s tafamidis (Vyndaqel, Vyndamax) and BridgeBio’s acoramidis (Attruby).
Abbott has received an investigational device exemption from the FDA for a new clinical trial evaluating the safety and effectiveness of using its coronary IVL technology. The trial is expected to enroll up to 335 U.S. patients.
Almost two in five physicians suffered moral distress in the two weeks leading up to their being asked about it by researchers. That was a markedly larger slice than the team observed in the general U.S. working population.
